… Important advancements in the treatment of non-small cell lung cancer (NSCLC) have been
achieved over the past two decades, increasing our understanding of the disease biology …

… lung cancers—KRAS—… cancers without targetable mutations, those with targetable mutations
who have progressed through targeted therapy, and those with squamous cell lung cancers…

… Among patients with non–small-cell lung cancer (NSCLC), data on intratumor heterogeneity
and cancer genome evolution have been limited to small retrospective cohorts. We wanted …

… in the management of non-small cell lung cancer (NSCLC) with … This review will address
updates in lung cancer screening, … metastatic non-small cell lung cancer in the first-line setting …

… of non-small cell lung carcinoma (NSCLC): moving from targeted therapy to immunotherapy.
… in two types of non-small cell lung cancer: adenocarcinoma and squamous cell carcinoma. …

… Non-small cell lung cancer (NSCLC) accounts for the majority of all … There are two main
subtypes of lung cancer, small-cell lung carcinoma and non-small-cell lung carcinoma (NSCLC), …

… Worldwide, lung cancer is the most common cause of cancer-related deaths. Molecular
targeted therapies and immunotherapies for non-small-cell lung cancer (NSCLC) have improved …

… Lung cancer remains the leading cause of cancer deaths in … been made in the science of
non–small cell lung cancer (NSCLC). … The National Lung Screening Trial found a lung cancer …

… Keywords or some variation of combination keywords included nonsmall cell lung cancer
(NSCLC), locally advanced stage, resectable, unresectable, advanced stage, metastatic, …

Objectives: Review the etiology of non-small cell lung cancer. Describe the appropriate steps
for the evaluation of non-small cell lung cancer. Outline the management options for non-…